"BCG; cystitis; epididymitis; haematuria; intravesical immunotherapy; transurethral tumour resection"@en . . . "U uroteli\u00E1ln\u00EDch karcinom\u016F mo\u010Dov\u00E9ho m\u011Bch\u00FD\u0159e bez invaze do svaloviny s vysok\u00FDm rizikem progrese je indikov\u00E1na instila\u010Dn\u00ED terapie BCG. Tuto l\u00E9\u010Dbu je mo\u017Eno indikovat i u n\u00E1dor\u016F rizika st\u0159edn\u00EDho. Intravezik\u00E1ln\u00ED instilace mitomycinem u pacient\u016F s karcinomem st\u0159edn\u00EDho a vysok\u00E9ho rizika progrese. Je v\u0161ak zat\u00ED\u017Eena v\u011Bt\u0161\u00EDm v\u00FDskytem vedlej\u0161\u00EDch \u00FA\u010Dink\u016F."@cs . "Komplikace intravezik\u00E1ln\u00ED terapie svalovinu neinfiltruj\u00EDc\u00EDho uroteli\u00E1ln\u00EDho karcinomu mo\u010Dov\u00E9ho m\u011Bch\u00FD\u0159e vakc\u00EDnou bacillus Calmette-Guerine (BCG)"@cs . "H\u00E4ring, Zden\u011Bk" . "7"^^ . "Patients with non-invasive transitional cell carcinoma (TCC) a high risk of progresion may benefit from intravesical chemotherapy or immunotherapy. Intravesical BCG instillation has better outcomes than Mitomycin instillation in patients with moderate to gross risk of disease progression. However this is accompanied by a higher degree of side effects."@en . . . "RIV/00843989:_____/10:00101130!RIV11-MZ0-00843989" . "N\u011Bmec, David" . "U uroteli\u00E1ln\u00EDch karcinom\u016F mo\u010Dov\u00E9ho m\u011Bch\u00FD\u0159e bez invaze do svaloviny s vysok\u00FDm rizikem progrese je indikov\u00E1na instila\u010Dn\u00ED terapie BCG. Tuto l\u00E9\u010Dbu je mo\u017Eno indikovat i u n\u00E1dor\u016F rizika st\u0159edn\u00EDho. Intravezik\u00E1ln\u00ED instilace mitomycinem u pacient\u016F s karcinomem st\u0159edn\u00EDho a vysok\u00E9ho rizika progrese. Je v\u0161ak zat\u00ED\u017Eena v\u011Bt\u0161\u00EDm v\u00FDskytem vedlej\u0161\u00EDch \u00FA\u010Dink\u016F." . "5"^^ . . "Komplikace intravezik\u00E1ln\u00ED terapie svalovinu neinfiltruj\u00EDc\u00EDho uroteli\u00E1ln\u00EDho karcinomu mo\u010Dov\u00E9ho m\u011Bch\u00FD\u0159e vakc\u00EDnou bacillus Calmette-Guerine (BCG)" . "5"^^ . . . "2" . . "\u010Cesk\u00E1 urologie" . "RIV/00843989:_____/10:00101130" . "[4F57FEBAC415]" . . . . . . "Complications of treatment with bacillus Calmette-Guerin (BCG) in non-muscle-invasive bladder cancer"@en . "266785" . . . "Komplikace intravezik\u00E1ln\u00ED terapie svalovinu neinfiltruj\u00EDc\u00EDho uroteli\u00E1ln\u00EDho karcinomu mo\u010Dov\u00E9ho m\u011Bch\u00FD\u0159e vakc\u00EDnou bacillus Calmette-Guerine (BCG)"@cs . "Havr\u00E1nek, Ond\u0159ej" . . . . "14" . "Krhut, Jan" . . . "CZ - \u010Cesk\u00E1 republika" . "1211-8729" . . "Komplikace intravezik\u00E1ln\u00ED terapie svalovinu neinfiltruj\u00EDc\u00EDho uroteli\u00E1ln\u00EDho karcinomu mo\u010Dov\u00E9ho m\u011Bch\u00FD\u0159e vakc\u00EDnou bacillus Calmette-Guerine (BCG)" . "Complications of treatment with bacillus Calmette-Guerin (BCG) in non-muscle-invasive bladder cancer"@en . "V" . "Kr\u00E1l, Roman" .